GNH USA

Europe — EMA

Menopur

GNH USA supplies Menopur (Menotropin), a gonadotropin preparation for anovulatory infertility and IVF ovarian stimulation. Request a quote for global supply.

Menotrophin

Request sourcing

1
Pack/s

What is Menotrophin?

Menotropin, the active ingredient in Menopur, is a gonadotropin (FSH/LH) preparation presented as a powder for solution for injection for intramuscular, subcutaneous use. It treats infertility due to anovulation, supports controlled ovarian stimulation for assisted reproductive technologies, and manages hypogonadotropic hypogonadism in women. GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Menotrophin used for?

Menopur is a gonadotropin preparation used in reproductive hormone therapy to stimulate ovarian function. - Infertility due to anovulation: stimulates follicular development to enable ovulation. - Controlled ovarian stimulation for IVF: provides FSH/LH activity to support multiple follicle growth. - Hypogonadotropic hypogonadism: replaces deficient gonadotropins to restore ovarian function.

What are the side effects of Menotrophin?

Common Side Effects: - Injection site pain or erythema - Abdominal discomfort or bloating - Mild nausea or headache - Transient ovarian cyst formation - Mild fatigue

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS) - Severe allergic reaction or anaphylaxis - Thromboembolic events - Multiple pregnancy - Severe abdominal pain or visual disturbances - Acute renal failure

What precautions apply to Menotrophin?

Before initiating Menopur therapy, patients should be evaluated for ovarian response and underlying endocrine disorders. - Monitor estradiol levels: adjust dose based on hormonal response. - Assess ovarian cysts: avoid use if large cysts are present. - Use with caution in uncontrolled thyroid disease: stabilize thyroid function first. - Discontinue if signs of OHSS appear: seek immediate medical attention. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Menotrophin interact with?

Menopur may interact with other agents affecting ovarian stimulation. Major Interactions (Avoid): - GnRH agonist therapy: can cause excessive ovarian stimulation. - hCG administration: increases risk of OHSS. - Aromatase inhibitors: may counteract estrogen production. Moderate Interactions (Monitor Closely): - Oral contraceptives: may alter response to stimulation. - Steroid medications: can affect hormone balance and follicular development.

Frequently asked questions

What is Menopur used for?+
Menopur contains menotropin, a gonadotropin preparation used in fertility treatment to stimulate follicular development in women with anovulatory infertility, for controlled ovarian stimulation in assisted reproductive technologies such as IVF, and to treat hypogonadotropic hypogonadism.
How does menotropin work?+
Menotropin provides both follicle‑stimulating hormone (FSH) and luteinising hormone (LH) activity. The FSH component binds to receptors on granulosa cells, promoting follicle growth and estrogen synthesis, while the LH component activates receptors on theca cells and mature follicles, supporting androgen production and final maturation leading to ovulation.
What is the usual dose of Menopur?+
The dose of Menopur is individualized; a prescribing clinician determines the amount and schedule based on the patient’s ovarian response, body weight, and treatment protocol. Dosing may be adjusted during the stimulation cycle according to monitoring of follicular development and hormone levels.
Is Menopur safe during pregnancy or breastfeeding?+
Menopur is intended for use before conception to induce ovulation; its safety in established pregnancy has not been established, and it is generally not recommended during pregnancy. Limited data are available for breastfeeding, so the medication should be avoided unless the benefits outweigh potential risks as assessed by a healthcare professional.
How do I order Menopur from GNH USA?+
To order Menopur, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling if needed—and the necessary import documentation.
How does Menopur compare with other fertility agents?+
Menopur differs from recombinant FSH products by containing a natural mixture of FSH and LH activity, which can be advantageous in patients who require both hormones for optimal follicular development. Compared with pure FSH preparations, Menopur may reduce the need for separate LH supplementation, but individual response varies and treatment choice should be guided by clinical assessment.
How should Menopur be stored and handled?+
Menopur powder for injection must be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. The vial should remain in its original packaging until reconstitution, and any unused portion should be discarded according to local regulations after the recommended storage period.
How is Menopur administered?+
Menopur is supplied as a sterile powder that is reconstituted with a suitable diluent to create a solution for injection. The solution is administered by subcutaneous or intramuscular injection, typically once daily, under the supervision of a fertility specialist who provides instructions on injection technique and timing relative to the treatment cycle.
What are the most serious risks associated with Menopur?+
The most serious risks include ovarian hyperstimulation syndrome (OHSS), which can cause abdominal pain, rapid weight gain, and, in severe cases, thromboembolic events or renal failure; severe allergic reactions such as anaphylaxis; and the possibility of multiple pregnancy. Patients should be monitored closely for early signs of these complications.
Who should not use Menopur?+
Menopur is contraindicated in women with known hypersensitivity to menotropin or any excipients, uncontrolled thyroid disease, active ovarian cysts, ovarian tumors, or severe endometriosis. It should also be avoided in patients with uncontrolled hypertension, recent thromboembolic events, or those who are pregnant or breastfeeding unless specifically advised by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Menotrophin
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Ferring S.A.U.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU